医学
诊断优势比
心力衰竭
荟萃分析
内科学
接收机工作特性
生物标志物
半乳糖凝集素-3
梅德林
优势比
重症监护医学
林地
心脏病学
法学
化学
政治学
生物化学
作者
Yueh Sheng Chen,Weng Tein Gi,Tin Yun Liao,Meng Tse Gabriel Lee,Si Huei Lee,Wan‐Ting Hsu,Shy Shin Chang,Chien‐Chang Lee
出处
期刊:Biomarkers in Medicine
[Future Medicine]
日期:2016-03-01
卷期号:10 (3): 329-342
被引量:25
摘要
Galectin-3 (Gal-3) is a new biomarker for assessing prognosis of heart failure (HF) patients. This systemic review and meta-analysis aims to examine Gal-3's ability in assessing prognosis of HF patients.We searched MEDLINE and Embase up to November 2014. Test performance characteristics were summarized using forest plots and hierarchical summary receiver operating characteristic curves.The diagnostic odds ratio of Gal-3 in predicting mortality in chronic HF patients was 2.36 (95% CI: 1.71-3.26) and 2.30 (95% CI: 1.76-3.01) in acute HF patients.Elevated levels of Gal-3 are associated with mortality in both acute and chronic HF patients. However, current evidence does not support sole use of Gal-3 for prognosis evaluation of HF patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI